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Intravenous antibiotic therapy in cystic fibrosis: in 
hospital or at home? 
Over the past 30 yr there has been a dramatic rise in 
the life expectancy of patients with cystic fibrosis 
due to improvements in early diagnosis and manage- 
ment (1). However, the majority of patients still die 
in early adulthood from respiratory failure following 
repeated bacterial insult to the lungs. Although there 
are no agents which can permanently resolve airways 
colonization by Pseudomonas aeruginosa, the adminis- 
tration of repeated courses of intravenous (iv.) anti- 
biotics is an effective way of slowing down lung 
deterioration (2,3). Recurrent hospitalization for i.v. 
antibiotics inevitably leads to considerable demands 
on patients lifestyle and has given rise to a growing 
interest among specialist centres in the effectiveness of 
home therapy. 
Is home iv. antibiotic therapy effective? Strandvik 
et al. recently reviewed home intravenous therapy in 3 1 
cystic fibrosis patients aged between 4 and 67 years (4) 
all of whom had chronic airway colonization with 
P. aeruginosa. Eighty-nine percent of patients showed 
a good objective response to treatment with significant 
improvement in lung function and weight, while 
subjectively 96% preferred home to hospital therapy. 
Similar results have been shown by previous studies 
($6). In one of the few prospective studies looking at 
the relative benefit of home VS. hospital intravenous 
antibiotic therapy Donati et al. compared 26 children 
on home i.v. antibiotic therapy with 38 children 
treated in hospital. Both groups showed significant 
improvements in lung function. However, the hospital 
treated group had a slightly greater change in forced 
vital capacity (7.2% at home, 12.7% in hospital) and 
oxygen saturation (4.7% at home, 7.4% in hospital). 
Although further prospective cross-over studies look- 
ing at hospital vs. home intravenous antibiotic therapy 
need to be undertaken before definitive conclusions on 
the relative benefits of both therapies can be drawn, 
home i.v. treatment would seem to offer several advan- 
tages. What then are the advantages of home over 
hospital i.v. antibiotic therapy in patients with cystic 
fibrosis? Firstly, it may be more cost effective. Robson 
et al. reviewed the cost of running a cystic fibrosis unit 
between April 1989 and March 1990 and showed a 
significantly higher cost for hospital as compared to 
home i.v. antibiotic therapy (8). Studies from the 
U.S.A. also support the economic argument for using 
home rather than hospital i.v. treatment (9). Any 
savings might allow reallocation of funds to other 
services within the unit which are often over-burdened. 
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Secondly, several cystic fibrosis centres have recently 
reported the isolation of multi resistant Pseudomonas 
cepaciu organisms (10). Home therapy would help 
reduce the risk of cross-infection. Thirdly, there will be 
an improvement in patients’ quality of life by spending 
less time in hospital and avoiding disruption to family 
life. The advantages offered by home therapy are 
dependant on patient compliance with regular physio- 
therapy, diet and meticulous i.v. administration. It is 
therefore important that a well designed training pro- 
gramme to evaluate patients in their administration of 
iv. antibiotics is set up preferably by the specialist 
nurse, in order to maximize safety (11,12) and to select 
suitable patients for home therapy. Until recently, 
patients on home i.v. antibiotics would have to spend a 
large proportion of the day drawing up and adminis- 
tering their drugs (12). This task has been simplified 
by the development of the Homepump (Fresenius, 
Runcorn, Cheshire) and the disposable intermate in- 
fusion device (Caremark, Harlow, Essex) (13). Drug- 
filled balloon reservoirs produce a positive pressure 
driving force which delivers a predetermined and con- 
trolled flow rate of prescribed antibiotic. Thus the time 
and inconveniences of drawing up and administering 
treatment is greatly reduced. 
The aim of physicians providing cystic fibrosis 
care is to give the most effective treatment with the 
minimal interference to the patient’s lifestyle. Home 
therapy seems to fulfil these criteria and in carefully 
selected patients may be a reasonable alternative to 
hospitalization. 
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